Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Child Safety
As parents, we want to keep our children safe from harm. Take steps to keep your children safe:
- Install the right child safety seat in your car
- Teach children how to cross the street safely
- Make sure they wear the right gear and equipment for sports
- Install and test smoke alarms
- Store medicines, cleaners and other dangerous substances in locked cabinets
- Babyproof your home
- Don't leave small children unattended
It sits within Children and Teenagers and Safety Issues.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Child Safety
3,242 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension PeriodAgios Pharmaceuticals, Inc.
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaH. Lee Moffitt Cancer Center and Research Institute
- A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain TumoursIpsen
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)AbbVie
- Phase 3 Study of LUM-201 in Children With Growth Hormone DeficiencyLumos Pharma
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigrainePfizer
Research already completed
- The Safety and Efficacy of SYD-101 in Children With MyopiaSydnexis, Inc.
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldTakeda
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- First Aid and SafetyNemours Foundation
Related Issues
- Halloween Safety Tips: Costumes, Candy, and Colored Contact LensesFood and Drug Administration
- Novelty MakeupFood and Drug Administration
Statistics and Research
- Traffic-Related Pedestrian Injuries among Children in 2023Safe Kids Worldwide
Medical subject headings
Clinicians and researchers index this subject under Safety. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Child Safety, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.